Literature DB >> 12571470

Treatment of neuroblastoma in patients with neurocristopathy syndromes.

Eneida R Nemecek1, Robert W Sawin, Julie Park.   

Abstract

Neuroblastoma, a neoplasm of neural crest cell origin, occasionally presents in association with other neural crest abnormalities such as Hirschsprung disease, congenital central hypoventilation, autonomic disturbances, and other tumors. These associations have been termed "neurocristopathy syndromes." In the past, chemotherapy has not been considered for patients with neurocristopathy-associated neuroblastoma because of their complicated medical problems. The authors describe two patients with neurocristopathy syndromes from our institution who underwent surgery and standard chemotherapy treatment of their intermediate-risk neuroblastoma. They represent two of only three long-term disease-free survivors of neurocristopathy-associated neuroblastoma reported in the literature.

Entities:  

Mesh:

Year:  2003        PMID: 12571470     DOI: 10.1097/00043426-200302000-00015

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  4 in total

1.  Germline PHOX2B mutation in hereditary neuroblastoma.

Authors:  Yael P Mosse; Marci Laudenslager; Deepa Khazi; Alex J Carlisle; Cynthia L Winter; Eric Rappaport; John M Maris
Journal:  Am J Hum Genet       Date:  2004-10       Impact factor: 11.025

2.  Diagnostic identification of malignant cells in the cerebrospinal fluid by tumor-specific qRT-PCR.

Authors:  Cristina Rosanda; Claudio Gambini; Barbara Carlini; Massimo Conte; Bruno De Bernardi; Alberto Garaventa; Maria Valeria Corrias
Journal:  Clin Exp Metastasis       Date:  2006-09-22       Impact factor: 5.150

3.  Enhanced expression of MycN/CIP2A drives neural crest toward a neural stem cell-like fate: Implications for priming of neuroblastoma.

Authors:  Laura Kerosuo; Pushpa Neppala; Jenny Hsin; Sofie Mohlin; Felipe Monteleone Vieceli; Zsofia Török; Anni Laine; Jukka Westermarck; Marianne E Bronner
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-18       Impact factor: 11.205

Review 4.  The contribution of associated congenital anomalies in understanding Hirschsprung's disease.

Authors:  S W Moore
Journal:  Pediatr Surg Int       Date:  2006-03-04       Impact factor: 1.827

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.